Safe Fertility Group PCL

Safe Fertility Group PCL Net Margin

The Net Profit Margin of Safe Fertility Group PCL (SAFE.BK) as of Oct 25, 2026 is 20.13 %. In the previous year, Net Profit Margin was 23.78 % — a change of -15.37% (lower).

Net Margin

20.13 %

YoY

-15.37%

Last updated:

Net Profit Margin of Safe Fertility Group PCL is 2024 20.13 % . Net Profit Margin of Safe Fertility Group PCL was 2023 23.78 % . It decreases by -15.37% lower compared to the previous year.

Safe Fertility Group PCL's net margin stands at 20.1%, down from 22.3% several years earlier.

The Safe Fertility Group PCL Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2022
22.28 THB
Jan 1, 2023
23.78 THB
Jan 1, 2024
20.13 THB
The Safe Fertility Group PCL Net Margin history
YEARNet MarginYoY
20.13 %-15.37%
23.78 %+6.73%
22.28 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Safe Fertility Group PCL Stock analysis

What does Safe Fertility Group PCL do? Safe Fertility Group PCL operates in the medical assisted reproductive technology and medical laboratories sector in Thailand. The company provides fertility treatment centers and supports its services through subsidiaries like Next Generation Genomics Co., Ltd., which offers genetic diagnosis for embryos and fetuses, and Safe Wellness Company Limited, which delivers skin and beauty services. These subsidiaries serve customers from hospitals and obstetric clinics, enhancing the company's comprehensive healthcare offerings. The firm's revenue streams come from fertility treatments, genetic diagnostic services, and beauty services provided to medical institutions and clinics. Safe Fertility Group PCL's business model relies on its subsidiaries to expand service offerings, with Next Generation Genomics focusing on genetic testing and Safe Wellness targeting wellness and beauty needs. The company's primary clients are hospitals and obstetric clinics seeking specialized reproductive and genetic services. Revenue is generated through direct service provision at fertility centers and via partnerships with healthcare providers for genetic and beauty services. The company's core products include medical assisted reproductive technology services, genetic diagnosis for embryos and fetuses, and skin and beauty treatments. These are sold to hospitals and obstetric clinics as part of their healthcare service packages. Safe Fertility Group PCL's subsidiaries play a key role in delivering these services, ensuring a full spectrum of care from fertility treatment to post-treatment wellness solutions. Safe Fertility Group PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Safe Fertility Group PCL stock

Net Profit Margin of Safe Fertility Group PCL is 20.13 % in 2024.

Net Profit Margin of Safe Fertility Group PCL changed from 23.78 % to 20.13 %, representing a -15.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Safe Fertility Group PCL since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Safe Fertility Group PCL with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Safe Fertility Group PCL

All Key Metrics — Safe Fertility Group PCL